Matthias Baumann
Geen lopende functies
Profiel
Matthias Baumann formerly worked at FOCUS Clinical Drug Development GmbH, as Managing Director & Chief Scientific Officer in 2010, F.
Hoffmann-La Roche Ltd., as Medical Officer in 2002, MOLOGEN AG, as Chief Medical Officer from 2017 to 2020, Roche Diagnostics GmbH, as Head-Clinical Research & Development Group in 1998, NOXXON Pharma AG, as Chief Medical Officer from 2011 to 2017, and TME Pharma NV, as Chief Medical Officer.
Dr. Baumann received his doctorate degree in 1984 from Friedrich-Alexander University of Erlangen-Nuremberg.
Eerdere bekende functies van Matthias Baumann
Bedrijven | Functie | Einde |
---|---|---|
MOLOGEN AG | Hoofd Techniek/Wetenschap/O&O | 30-04-2020 |
TME PHARMA N.V. | Hoofd Techniek/Wetenschap/O&O | 30-04-2017 |
NOXXON Pharma AG
NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Hoofd Techniek/Wetenschap/O&O | 01-01-2017 |
FOCUS Clinical Drug Development GmbH
FOCUS Clinical Drug Development GmbH Miscellaneous Commercial ServicesCommercial Services FOCUS Clinical Drug Development GmbH provides drug and clinical research and development services. The company is based in Neuss, Germany. FOCUS Clinical Drug Development was acquired by Nuvisan GmbH on November 05, 2010. | Algemeen Directeur | 01-01-2010 |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01-01-2002 |
Opleiding van Matthias Baumann
Friedrich-Alexander University of Erlangen-Nuremberg | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
MOLOGEN AG | Commercial Services |
TME PHARMA N.V. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
NOXXON Pharma AG
NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Health Technology |
FOCUS Clinical Drug Development GmbH
FOCUS Clinical Drug Development GmbH Miscellaneous Commercial ServicesCommercial Services FOCUS Clinical Drug Development GmbH provides drug and clinical research and development services. The company is based in Neuss, Germany. FOCUS Clinical Drug Development was acquired by Nuvisan GmbH on November 05, 2010. | Commercial Services |
Roche Diagnostics GmbH
Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Commercial Services |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |